Articles

Reduced hematopoietic stem cell frequency predicts outcome in acute myeloid leukemia

Department of Medicine V, Heidelberg University, Germany
Institute of Applied Mathematics, Interdisciplinary Center for Scientific Computing (IWR), BIOQUANT, Heidelberg University, Germany
Department of Medicine V, Heidelberg University, Germany;Division of Stem Cells and Cancer, Deutsches Krebsforschungszentrum (DKFZ), Heidelberg, Germany;Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH), Germany
Department of Medicine V, Heidelberg University, Germany
Department of Medicine V, Heidelberg University, Germany
Department of Medicine V, Heidelberg University, Germany
Department of Medicine V, Heidelberg University, Germany
Department of Medicine V, Heidelberg University, Germany
Department of Medicine V, Heidelberg University, Germany
Department of Medicine V, Heidelberg University, Germany
Department of Medicine V, Heidelberg University, Germany;Clinical Cooperation Unit Molecular Hematology/Oncology, Deutsches Krebsforschungszentrum (DKFZ), Heidelberg, Germany
Department of Medicine V, Heidelberg University, Germany
Division of Stem Cells and Cancer, Deutsches Krebsforschungszentrum (DKFZ), Heidelberg, Germany;Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH), Germany
Institute of Human Genetics, Heidelberg University, Germany
Division of Stem Cells and Cancer, Deutsches Krebsforschungszentrum (DKFZ), Heidelberg, Germany;Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH), Germany;German Cancer Consortium (DKTK), Heidelberg, Germany
Institute of Applied Mathematics, Interdisciplinary Center for Scientific Computing (IWR), BIOQUANT, Heidelberg University, Germany
Department of Medicine V, Heidelberg University, Germany
Department of Medicine V, Heidelberg University, Germany;German Cancer Consortium (DKTK), Heidelberg, Germany
Vol. 102 No. 9 (2017): September, 2017 https://doi.org/10.3324/haematol.2016.163584